A von Hippel-Lindau disease-associated microcystic adenoma of the ethmoid sinus: Case report

Neurosurgery

Volumn 69, Issue 4, 2011, Pages

  Xu, David S ^a   Dirks, Michael S ^a   Quezado, Martha M ^b   Lubensky, Irina A ^b   Zhuang, Zhengping ^a   Lonser, Russell R ^a   Asthagiri, Ashok R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cranial base tumor; Microcystic adenoma; von Hippel Lindau disease

Indexed keywords

CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; INHIBIN A; VON HIPPEL LINDAU PROTEIN;

ADENOMA; ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DNA ISOLATION; ETHMOID SINUS; FEMALE; HEMANGIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MICROCYSTIC ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY HALLUCINATION; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; VON HIPPEL LINDAU DISEASE;

ADENOMA; ADULT; ETHMOID SINUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PARANASAL SINUS NEOPLASMS; VON HIPPEL-LINDAU DISEASE;

EID: 80053626650     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318223b7a7     Document Type: Article

References (22)

1. Maher ER, Iselius L, Yates JR, et al. von Hippel-Lindau disease: A genetic study. J Med Genet. 1991;28(7):443-447.
2. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: Evidence for a complex genetic locus. Lancet. 1991;337(8749):1052- 1054.
3. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993 1993;260(5112):1317-1320.
4. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361(9374):2059-2067.
5. Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med. 2004;350(24):2481-2486.
6. Sinkre PA, Murakata L, Rabin L, Hoang MP, Albores-Saavedra J. Clear cell carcinoid tumor of the gallbladder: Another distinctive manifestation of von Hippel-Lindau disease. Am J Surg Pathol. 2001;25(10):1334-1339.
7. KosmahlM,Wagner J, Peters K, Sipos B, Kloppel G. Serous cystic neoplasms of the pancreas: An immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol. 2004;28(3):339-346.
8. Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): A clinicopathologic study of 34 cases.AmJ Clin Pathol. 1978;69(3):289-298.
9. Klein J, Zhuang Z, Lubensky I, Colby TV, Martinez F Jr, Leslie KO. Multifocal microcysts and papillary cystadenoma of the lung in von Hippel-Lindau disease. Am J Surg Pathol. 2007;31(8):1292-1296.
10. Lamiell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of as single kindred. Medicine (Baltimore). 1989;68(1):1-29.
11. Persing JA, Jane JA, Levine PA, Cantrell RW. The versatile frontal sinus approach to the floor of the anterior cranial fossa. Technical note. J Neurosurg. 1990;72(3):513-516.
12. Mohr VH, Vortmeyer AO, Zhuang Z, et al. Histopathology and molecular genetics of multiple cysts and microcystic (Serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol. 2000 2000;157(5):1615-1621.
13. Jarrell ST, Vortmeyer AO, Linehan WM, Oldfield EH, Lonser RR. Metastases to hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2006;105(2):256-263.
14. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24(2):203-210.
15. Jung S-M, Kuo T-t. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol. 2004;18(6):788-794.
16. Andrew SM, Gradwell E. Immunoperoxidase labeled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol. 1986;39(8):917-919.
17. Gouldesbrough DR, Bell JE, Gordon A. Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma. J Clin Pathol. 1988;41(8):861-865.
18. Weinbreck NMD, Marie BMD, Bressenot AMD, et al. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: Utility of aquaporin1 combined with cytokeratin AE1/ AE3 immunostaining. Am J Surg Pathol. 2008;32(7):1051-1059.
19. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: An undifferentiated mesenchymal tumor. Mod Pathol. 1989;2(6):638-651.
20. Park DM, Zhuang Z, Chen L, et al. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007;4(2):e60.
21. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel-Lindau disease. Gastroenterology. 2000;119(4):1087-1095.
22. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):82-94.